Title:
LIGAND CONJUGATES FOR DELIVERY OF THERAPEUTICALLY ACTIVE AGENTS
Document Type and Number:
WIPO Patent Application WO/2023/011597
Kind Code:
A1
Abstract:
Provided are compounds of Formula (I) as novel ligand conjugates, and use thereof for delivering therapeutically active agents. The compounds have the advantages for in vitro and/or in vivo delivery of therapeutically active agents, e.g., iRNA agents.
Inventors:
XU XIAODONG (CN)
MO CHENG (CN)
CHEN SHIJIA (CN)
MO CHENG (CN)
CHEN SHIJIA (CN)
Application Number:
PCT/CN2022/110327
Publication Date:
February 09, 2023
Filing Date:
August 04, 2022
Export Citation:
Assignee:
HEPAGENE THERAPEUTICS HK LTD (CN)
International Classes:
A61K47/54; A61P31/14
Domestic Patent References:
| WO2017023817A1 | 2017-02-09 | |||
| WO2016077321A1 | 2016-05-19 | |||
| WO2021113851A2 | 2021-06-10 | |||
| WO2009073809A2 | 2009-06-11 |
Foreign References:
| CN110997917A | 2020-04-10 | |||
| CN108779465A | 2018-11-09 |
Attorney, Agent or Firm:
CHENG & PENG INTELLECTUAL PROPERTY LAW OFFICE (CN)
Download PDF:
Previous Patent: AMIDE COMPOUND AND USE THEREOF
Next Patent: HOOP-TYPE TEE JOINT FOR CPVC FIRE-FIGHTING PLASTIC PIPE SYSTEM
Next Patent: HOOP-TYPE TEE JOINT FOR CPVC FIRE-FIGHTING PLASTIC PIPE SYSTEM